| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.01 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |